Zeremski M - Search Results

1

Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users.

Zeremski M, Shu MA, Brown Q, Wu Y, Des Jarlais DC, Busch MP, Talal AH, Edlin BR. Zeremski M, et al. J Viral Hepat. 2009 Jan;16(1):10-20. doi: 10.1111/j.1365-2893.2008.01016.x. Epub 2008 Jul 17. J Viral Hepat. 2009. PMID: 18647233 Free PMC article.

2

The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.

Zeremski M, Petrovic LM, Talal AH. Zeremski M, et al. J Viral Hepat. 2007 Oct;14(10):675-87. doi: 10.1111/j.1365-2893.2006.00838.x. J Viral Hepat. 2007. PMID: 17875002 Review.

3

Integrated internist - addiction medicine - hepatology model for hepatitis C management for individuals on methadone maintenance.

Martinez AD, Dimova R, Marks KM, Beeder AB, Zeremski M, Kreek MJ, Talal AH. Martinez AD, et al. Among authors: zeremski m. J Viral Hepat. 2012 Jan;19(1):47-54. doi: 10.1111/j.1365-2893.2010.01411.x. Epub 2010 Dec 3. J Viral Hepat. 2012. PMID: 21129131 Free PMC article.

4

Hepatitis C virus-specific immune responses in noninjecting drug users.

Zeremski M, Makeyeva J, Arasteh K, Des Jarlais DC, Talal AH. Zeremski M, et al. J Viral Hepat. 2012 Aug;19(8):554-9. doi: 10.1111/j.1365-2893.2011.01573.x. Epub 2012 Feb 22. J Viral Hepat. 2012. PMID: 22762139 Free PMC article.

5

Induction of CXCR3- and CCR5-associated chemokines during acute hepatitis C virus infection.

Zeremski M, Hooker G, Shu MA, Winkelstein E, Brown Q, Des Jarlais DC, Tobler LH, Rehermann B, Busch MP, Edlin BR, Talal AH. Zeremski M, et al. J Hepatol. 2011 Sep;55(3):545-553. doi: 10.1016/j.jhep.2010.12.033. Epub 2011 Jan 21. J Hepatol. 2011. PMID: 21256906 Free PMC article.

6

Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis.

Dimova RB, Zeremski M, Jacobson IM, Hagan H, Des Jarlais DC, Talal AH. Dimova RB, et al. Among authors: zeremski m. Clin Infect Dis. 2013 Mar;56(6):806-16. doi: 10.1093/cid/cis1007. Epub 2012 Dec 7. Clin Infect Dis. 2013. PMID: 23223596 Free PMC article. Review.

7

Interferon gamma-inducible protein 10: a predictive marker of successful treatment response in hepatitis C virus/HIV-coinfected patients.

Zeremski M, Markatou M, Brown QB, Dorante G, Cunningham-Rundles S, Talal AH. Zeremski M, et al. J Acquir Immune Defic Syndr. 2007 Jul 1;45(3):262-8. doi: 10.1097/QAI.0b013e3180559219. J Acquir Immune Defic Syndr. 2007. PMID: 17414926 Clinical Trial.

8

Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C.

Zeremski M, Petrovic LM, Chiriboga L, Brown QB, Yee HT, Kinkhabwala M, Jacobson IM, Dimova R, Markatou M, Talal AH. Zeremski M, et al. Hepatology. 2008 Nov;48(5):1440-50. doi: 10.1002/hep.22500. Hepatology. 2008. PMID: 18798334 Free PMC article.

9

Hepatitis C viral kinetics during treatment of hepatitis C virus/HIV coinfected patients.

Zeremski M, Talal AH. Zeremski M, et al. Curr Opin HIV AIDS. 2007 Nov;2(6):489-95. doi: 10.1097/COH.0b013e3282f0dcf9. Curr Opin HIV AIDS. 2007. PMID: 19372932

10

Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection.

Zeremski M, Dimova R, Brown Q, Jacobson IM, Markatou M, Talal AH. Zeremski M, et al. J Infect Dis. 2009 Dec 1;200(11):1774-80. doi: 10.1086/646614. J Infect Dis. 2009. PMID: 19848607

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters